Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket



  • Clearmind Medicine Inc. CMND jumped 69.3% to $0.8480 in pre-market trading after dropping 12% on Tuesday. Clearmind Medicine recently announced a $3.5 million public offering priced at $0.78 per share.
  • a.k.a. Brands Holding Corp. AKA gained 32.6% to $0.5393 in pre-market trading after the company announced preliminary unaudited Q1 2023 results. The company sees Q1 net sales of $120 million, versus previous estimate of $113 million to $116 million.
  • Getaround, Inc. GETR surged 26.1% to $0.3216 in pre-market trading. Getaround recently said it sees preliminary FY22 total revenues of $59 million to $60 million.
  • Bed Bath & Beyond Inc. BBBY shares climbed 24.8% to $0.4282 in pre-market trading after jumping 22% on Tuesday. Bed Bath & Beyond recently filed preliminary prospectus for resale of up to 111.7 million shares of common stock by B. Riley Principal Capital II.
  • Intuitive Machines, Inc. LUNR climbed 24.8% to $12.98 in pre-market trading. Intuitive Machines said The National Aeronautics and Space Administration awarded Space & Technology Solutions, the DBA for Space Networks Solutions LLC, a joint venture led by Intuitive Machines with KBR, a cost-plus-fixed-fee indefinite-delivery, indefinite-quantity contract meant to support work related to the Joint Polar Satellite System, NASA’s Exploration and In-space Services.
  • China Jo-Jo Drugstores, Inc. CJJD gained 17.3% to $0.7910 in pre-market trading. China Jo-Jo Drugstores shares dropped over 85% on Tuesday after the company announced a $7 million registered direct offering.
  • Western Alliance Bancorporation WAL gained 15.4% to $37.50 in pre-market trading after the company reported better-than-expected Q1 earnings.
  • Genprex, Inc. GNPX gained 14.7% to $1.09 in pre-market trading after gaining 3% on Tuesday.
  • Metropolitan Bank Holding Corp. MCB climbed 14.6% to $35.31 in pre-market trading following better-than-expected Q1 earnings.
  • SenesTech, Inc. SNES gained 14.2% to $1.77 in pre-market trading after gaining 21% on Tuesday. HC Wainwright & Co. reiterated SenesTech with a Buy and maintained a $4 price target.


  • Oblong, Inc. OBLG fell 22% to $2.69 in pre-market trading after jumping more than 61% on Tuesday.
  • Super League Gaming, Inc. SLGG shares dropped 21% to $0.5224 in pre-market trading. Super League Gaming shares jumped over 54% on Tuesday after the company and LandVault announced a strategic partnership to provide brands with scalable solutions to bridge the gap between Web2 and Web3.
  • FOXO Technologies Inc. FOXO fell 18.4% to $0.6230 in pre-market after dropping 8% on Tuesday. FOXO Technologies announced resignation of Taylor Fay, Chief Operating Officer, effective April 28, 2023.
  • Gamida Cell Ltd. GMDA fell 18.3% to $1.38 in pre-market trading. Gamida Cell shares jumped over 50% on Tuesday after the company announced it received FDA approval for Omisirge allogeneic cell therapy.
  • Panbela Therapeutics, Inc. PBLA fell 14.2% to $0.5327 in pre-market trading after gaining around 14% on Tuesday. Panbela Therapeutics recently announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
  • Biocept, Inc. BIOC fell 14.1% to $0.3010 in pre-market trading. Biocept recently reported 2022 loss of $1.89 per share.
  • SAB Biotherapeutics, Inc. SABS fell 13.4% to $0.94 in pre-market trading. SAB Therapeutics shares gained around 42% on Tuesday after the company announced the FDA has granted Breakthrough Therapy Designation to SAB-176.
  • United Insurance Holdings Corp. UIHC shares fell 12.8% to $1.57 in pre-market trading after dipping over 48% on Tuesday.
  • Sonnet BioTherapeutics Holdings, Inc. SONN fell 12.7% to $0.2910 in pre-market trading after the company announced updated clinical data for SON-1010 at the 2023 American Association for Cancer Research Annual Meeting.
  • Windtree Therapeutics, Inc. WINT fell 11.7% to $5.88 in pre-market trading after dropping over 19% on Tuesday. Windtree Therapeutics recently announced the European Patent Office has granted Patent No. 3599243, providing patent coverage for the dual mechanism SERCA2a Activator class of drug candidates.

Now Read This: Top 5 Industrials Stocks You May Want To Dump This Quarter

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!